c-Fms tyrosine kinase inhibitors (3-Dimensional Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namec-Fms tyrosine kinase inhibitors (3-Dimensional Pharmaceuticals)
Drug Alias NameCSF-1 antagonists (3-Dimensional Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophage Colony Stimulating Factor 1 inhibitorsTyrosine-protein kinase receptor FLT3 inhibitors
TargetsTyrosine-protein kinase receptor FLT3Macrophage Colony Stimulating Factor 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator Companies3-Dimensional Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies3-Dimensional Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A